MedPath

PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk

Not Applicable
Completed
Conditions
Symptomatic Severe Aortic Stenosis
Interventions
Device: SAVR Implantation
Device: TAVR Implantation with SAPIEN XT
Registration Number
NCT01314313
Lead Sponsor
Edwards Lifesciences
Brief Summary

The purpose of this trial is to determine the safety and effectiveness of the Edwards SAPIEN XT transcatheter heart valve and delivery systems which are intended for use in patients with symptomatic, calcific, severe aortic stenosis.

Detailed Description

The PIIA cohort is a prospective multi-center trial undergoing aortic valve replacement for severe aortic stenosis. Patients randomized to the treatment arm will receive an Edwards SAPIEN XT THV with either transfemoral, transapical or transaortic delivery access. Patients in the control arm will receive a surgical bioprosthetic heart valve via aortic valve replacement surgery.

To assure that patients with an STS score ≥ 4% have been selected.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2032
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control: SAVRSAVR ImplantationSAVR (surgical aortic valve replacement) is the control arm
PIIA - SAPIEN XTTAVR Implantation with SAPIEN XTPIIA is operable group
Primary Outcome Measures
NameTimeMethod
All-cause Death or Disabling Stroke to Two Years2 Years

All-cause Death or Disabling Stroke (Edwards SAPIEN XT THV vs SAVR)

Secondary Outcome Measures
NameTimeMethod
Adjusted Days Alive and Out of Hospital (DAOH) to Two Years2 years

The number of days the patients are alive and out of the hospital.

6MWT Change From BaselineBaseline and 2 years

Six Minute Walk Test change from baseline to 2 years

Effective Orifice Area (EOA)2 years
Total Aortic Regurgitation (AR) at 2 Years2 years

Total aortic regurgitation was assessed by the core lab as "Grade 0" = None, "Grade 1+" = Trace, "Grade 2+" = Mild, "Grade 3+" = Moderate and "Grade 4+" = Severe. Total regurgitation at two year was analyzed in the valve implant population.

NYHA Classification at 2 Years2 years

New York Heart Association (NYHA), functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I - IV, with the lowest as no limitations and the highest unable to carry on any physical activity without discomfort.

Trial Locations

Locations (57)

Rush University Medical Center

🇺🇸

Chicago, Illinois, United States

Cedars-Sinai Medical Center

🇺🇸

Los Angeles, California, United States

Morton Plant Hospital

🇺🇸

Clearwater, Florida, United States

Northshore

🇺🇸

Evanston, Illinois, United States

University of Maryland, Baltimore

🇺🇸

Baltimore, Maryland, United States

Newark Beth Israel Medical Center

🇺🇸

Newark, New Jersey, United States

University of Pennsylvania Hospital

🇺🇸

Philadelphia, Pennsylvania, United States

York Hospital

🇺🇸

York, Pennsylvania, United States

Arkansas Heart Hospital/Clinic

🇺🇸

Little Rock, Arkansas, United States

Scripps Memorial Hospital

🇺🇸

La Jolla, California, United States

Washington University - Barnes Jewish Hospital

🇺🇸

Saint Louis, Missouri, United States

Dartmouth Hitchcock Medical Center

🇺🇸

Lebanon, New Hampshire, United States

The University of Iowa

🇺🇸

Iowa City, Iowa, United States

Nebraska Heart Institute

🇺🇸

Lincoln, Nebraska, United States

Washington Hospital Center

🇺🇸

Washington, District of Columbia, United States

Columbia University Medical Center

🇺🇸

New York, New York, United States

William Beaumont Hospital

🇺🇸

Royal Oak, Michigan, United States

Cooper University

🇺🇸

Camden, New Jersey, United States

Winthrop University Hospital

🇺🇸

Mineola, New York, United States

The Heart Hospital Baylor Plano

🇺🇸

Dallas, Texas, United States

Medical City Dallas

🇺🇸

Dallas, Texas, United States

University of Wisconsin - Madison

🇺🇸

Madison, Wisconsin, United States

East Carolina Heart Institute at East Carolina University

🇺🇸

Greenville, North Carolina, United States

IHC Health Services Inc. dba Intermountain Medical Center

🇺🇸

Murray, Utah, United States

Cleveland Clinic Foundation

🇺🇸

Cleveland, Ohio, United States

Brigham and Women's Hospital

🇺🇸

Boston, Massachusetts, United States

University of Washington

🇺🇸

Seattle, Washington, United States

University of Miami Hospital Miller School of Medicine

🇺🇸

Miami, Florida, United States

Indiana University Health-Methodist Hospital

🇺🇸

Indianapolis, Indiana, United States

Scripps Green Hospital

🇺🇸

La Jolla, California, United States

Stanford University Medical Center

🇺🇸

Stanford, California, United States

Emory University

🇺🇸

Atlanta, Georgia, United States

Northwestern University

🇺🇸

Chicago, Illinois, United States

Prairie Education and Research Cooperative

🇺🇸

Springfield, Illinois, United States

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

New York Presbyterian Hospital - Cornell

🇺🇸

New York, New York, United States

Baptist Memorial Hospital

🇺🇸

Memphis, Tennessee, United States

The University of Texas Health Science Center at Houston

🇺🇸

Houston, Texas, United States

Sentara Norfolk General Hospital

🇺🇸

Norfolk, Virginia, United States

Minneapolis Heart Institute Foundation

🇺🇸

Minneapolis, Minnesota, United States

The Lindner Center for Research & Education at The Christ Hospital

🇺🇸

Cincinnati, Ohio, United States

University of Texas Health Science Center at San Antonio (UTHSCSA)

🇺🇸

San Antonio, Texas, United States

Institut Universitaire de Cardiologie et de Pneumologie de Québec

🇨🇦

Quebec, Canada

University of Colorado Hospital

🇺🇸

Denver, Colorado, United States

Henry Ford Hospital

🇺🇸

Detroit, Michigan, United States

Oklahoma Cardiovascular Research Group

🇺🇸

Oklahoma City, Oklahoma, United States

Mayo Clinic-Saint Marys Hospital

🇺🇸

Rochester, Minnesota, United States

Providence Heart & Vascular Institute at Providence St. Vincent Medical Center

🇺🇸

Portland, Oregon, United States

St. Paul's Hospital, Providence Health Care

🇨🇦

Vancouver, British Columbia, Canada

University of Virginia

🇺🇸

Charlottesville, Virginia, United States

Mercy General Hospital

🇺🇸

Sacramento, California, United States

Ochsner Clinic Foundation

🇺🇸

New Orleans, Louisiana, United States

UC Davis Medical Center

🇺🇸

Sacramento, California, United States

The Jewish Hospital Medical Center

🇺🇸

Louisville, Kentucky, United States

St. Luke's Hospital - Mid America Heart Institute

🇺🇸

Kansas City, Missouri, United States

Medical University of South Carolina

🇺🇸

Charleston, South Carolina, United States

Austin Heart, PLLC

🇺🇸

Austin, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath